PharmaEssentia Corp. Patent applications |
Patent application number | Title | Published |
20130184451 | NOVEL SYNTHESIS OF 5-DEOXY-5'-FLUOROCYTIDINE COMPOUNDS - This invention relates to a process of synthesizing a β-nucleoside compound of formula (I): | 07-18-2013 |
20120259106 | ASYNTHESIS OF B-NUCLEOSIDES - A process of stereoselectively synthesizing β-nucleoside, e.g., 2′-deoxy-2,2′-difluorocytidine, is described. The process includes reacting a tetrahydrofuran compound of the following formula: | 10-11-2012 |
20110262380 | THEAPEUTIC USE OF PROTEIN-POLYMER CONJUGATES - This invention relates to use protein-polymer conjugates described in the specification to treat various diseases, including disease is idiopaic myelofibrsis, polycythaemia vera, and essential thromobocythaemia. | 10-27-2011 |
20110098451 | PEPTIDE-POLYMER CONJUGATES - This invention relates to a conjugate of a polymer moiety and an erythropoietin moiety. | 04-28-2011 |
20100029907 | PEPTIDE-POLYMER CONJUGATES - This invention relates to a conjugate of a polymer moiety and an interferon-β moiety, an erythropoietin moiety, or a growth hormone moiety. | 02-04-2010 |
20090269306 | N-TERMINAL MODIFIED INTERFERON-ALPHA - A method of reducing formation of non-natural disulfide bonds in a mature IFN-α by adding one or more amino acid residues to its N-terminus cystein. Also disclosed herein is the IFN-α thus modified. | 10-29-2009 |
20090053177 | PROTEIN-POLYMER CONJUGATES - This invention relates to protein-polymer conjugates described in the specification. Also disclosed are a method for preparing a protein-polymer conjugate and its use in treating hepatitis B virus or hepatitis C virus infection. | 02-26-2009 |